ABVC BIOPHARMA, INC. - Spin-Off
ABVC Biopharma, Inc. will execute a spin-off transaction, with the Parent providing transitional administrative services to the Subsidiary following the distribution as outlined in the Separation Agreement.
Why this matters
ABVC Biopharma, Inc., a Nevada-incorporated company operating in the pharmaceutical preparations industry, is executing a spin-off transaction. This move involves separating a subsidiary from the parent company, with ABVC Biopharma providing transitional administrative services to the new entity as outlined in the Separation Agreement. The spin-off is part of a broader merger transaction where the parent company will not be the surviving entity, and the subsidiary will assume obligations under the agreement. The mechanics of the spin-off, including distribution or record dates, have not been detailed in the available filings.